Quantbot Technologies LP Vanda Pharmaceuticals Inc. Transaction History

Quantbot Technologies LP

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$3.47 - $4.61 $25,331 - $33,653	7,300 New	7,300 $30,000
Q3 2023 Nov 07, 2023	SELL	$4.28 - $6.57 $26,964 - $41,391	-6,300 Reduced 53.39%	5,500 $23,000
Q2 2023 Aug 08, 2023	BUY	$5.9 - $6.95 $31,270 - $36,835	5,300 Added 81.54%	11,800 $77,000
Q1 2023 May 12, 2023	BUY	$6.18 - $7.99 $40,170 - $51,935	6,500 New	6,500 $44,000
Q3 2022 Nov 07, 2022	BUY	$9.44 - $11.76 $86,848 - $108,192	9,200 New	9,200 $90,000
Q2 2021 Aug 12, 2021	SELL	$15.71 - $21.51 $104,612 - $143,235	-6,659 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$13.42 - $20.28 $89,363 - $135,044	6,659 New	6,659 $100,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $7,064 - $9,111	-758 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$9.66 - $12.02 $7,322 - $9,111	758 New	758 $8,000
Q1 2020 May 13, 2020	SELL	$7.5 - $16.8 $39,000 - $87,360	-5,200 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$12.38 - $17.47 $14,348 - $20,247	1,159 Added 28.68%	5,200 $85,000
Q3 2019 Nov 12, 2019	BUY	$12.27 - $15.79 $49,583 - $63,807	4,041 New	4,041 $53,000
Q4 2018 Feb 13, 2019	SELL	$18.97 - $31.47 $66,869 - $110,931	-3,525 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$18.25 - $23.0 $101,597 - $128,041	-5,567 Reduced 61.23%	3,525 $80,000
Q2 2018 Aug 13, 2018	BUY	$13.95 - $19.15 $126,833 - $174,111	9,092 New	9,092 $173,000
Q1 2018 May 11, 2018	SELL	$14.05 - $20.2 $9,539 - $13,715	-679 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$12.85 - $18.1 $35,016 - $49,322	-2,725 Reduced 80.05%	679 $10,000
Q3 2017 Nov 07, 2017	BUY	$15.4 - $18.85 $52,421 - $64,165	3,404	3,404 $60,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.